PN
Last reporting period 30 Sep, 2023
Updated —
Last price
—
Market cap $B
1.332
Exchange
XNAS - Nasdaq
511 %
Last period Growth rate volatility (2y)
What is Growth rate volatility (2y) ?
An indicator of the degree of volatility in the growth rate of a company's profit in the medium-term retrospective. A value below the average growth rate for the same period is the benchmark for calculating a company rating in Eyestock model.
See also POINT Biopharma
Company Analysis
PNT valuation, rating, competitors, insights and company profile
Eyestock Rating
PNT financial analysis by Eyestock methodology
Valuation
PNT valuation using historical relative method
Statements
PNT Income Statements, Balance Sheet and Cash Flow Statements
Dividends
PNT dividend yield and annual dividend
An indicator of the degree of volatility in the growth rate of a company's profit in the medium-term retrospective. A value below the average growth rate for the same period is the benchmark for calculating a company rating in Eyestock model.
POINT Biopharma`s Growth rate volatility (2y) for the period ended 2023-09-30 is 511 %
